| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Essential Marketing Unites the P's With the Q's Marketing Models to Increase Sales For Results |
|
Main Subject - Essential Marketing Unites the P's With the Q's Marketing Models to Increase Sales For Results
Essential marketing strategies and tactics need to go beyond the current marketing models for businesses to increase sales for better bottom According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product line results. Many are familiar with the traditional marketing models of the P's and Q's. As change has increased information, so must the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in se models be increased to reflect the trends within the 21st century marketplace. One of the most frequently used marketing models a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. re The 4 - P's:
However in the 21st century busi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ness world, 3 new P's have emerged:
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e call this niche marketing. Where is your position relative to your competition? Position is determined through the research within your s ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc trategic plan. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi focus. By researching specific preferences, may allow you to create your own unique marketing place or what is called the Blue Ocean Str nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ategy by authors Kim and Mauborgne. and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ coach, I am continually amazed at many businesses who cannot define their prospects. If you do not begin with the correct identification, ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi hen you are probably wasting your marketing resources of time, energy and dollars. Again, this is due in many cases to a lack of a strategic ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a plan.
For many marketing experts, the Q's of marketing included only quality and quantity. Yet in today's complicated business dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod world, another Q has emerged that being Qualify. Your marketing efforts should further qualify your prospects by showcasing your expertise cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin as well as the results from your products or services. The use of testimonials is one such qualifying strategy. When you incorporate the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen seven P's and the three Q's, you will secure the big R or results. (For some marketing experts, this is called the fifth P of Performance.) t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel These results should ultimately increase sales. Technology today allows even the smallest business owner to track results. Failure to measu ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust re the results of your marketing strategies and tactics will cost you in terms of lost sales, lost market presence and potentially a lost bu y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products siness. The last several years I have researched numerous marketing models in my own marketing efforts as well as when working with clients . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de . I can personally attest that these 7-P's and 3-Q's are critical to my own success as a business coach. The U.S. economy is growing and i elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip f you want a piece of the American Pie now is the time to revisit your marketing model to turn today's goals into tomorrow's desired results tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Radio Advertising Commandments - Part 1 Is a Career Change on Your Horizon?
|